Thrivent Financial for Lutherans Sells 2,023 Shares of Avanos Medical, Inc. (NYSE:AVNS)

Thrivent Financial for Lutherans reduced its position in Avanos Medical, Inc. (NYSE:AVNS) by 5.3% in the third quarter, HoldingsChannel.com reports. The firm owned 36,084 shares of the company’s stock after selling 2,023 shares during the period. Thrivent Financial for Lutherans’ holdings in Avanos Medical were worth $867,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently modified their holdings of AVNS. KBC Group NV raised its stake in Avanos Medical by 63.0% during the 3rd quarter. KBC Group NV now owns 2,833 shares of the company’s stock valued at $68,000 after purchasing an additional 1,095 shares during the period. Canada Pension Plan Investment Board purchased a new stake in Avanos Medical during the 2nd quarter valued at approximately $70,000. XTX Topco Ltd bought a new stake in shares of Avanos Medical during the second quarter valued at approximately $202,000. Magnetar Financial LLC purchased a new position in shares of Avanos Medical in the second quarter worth $248,000. Finally, Caxton Associates LP boosted its position in shares of Avanos Medical by 13.6% during the second quarter. Caxton Associates LP now owns 17,035 shares of the company’s stock worth $339,000 after acquiring an additional 2,034 shares during the last quarter. 95.17% of the stock is owned by hedge funds and other institutional investors.

Avanos Medical Price Performance

NYSE:AVNS opened at $19.03 on Wednesday. The business’s 50-day moving average is $21.05 and its 200 day moving average is $21.52. Avanos Medical, Inc. has a 12 month low of $17.39 and a 12 month high of $25.36. The company has a market capitalization of $874.62 million, a P/E ratio of 55.97 and a beta of 0.95. The company has a current ratio of 2.22, a quick ratio of 1.46 and a debt-to-equity ratio of 0.12.

Analysts Set New Price Targets

Separately, StockNews.com downgraded shares of Avanos Medical from a “strong-buy” rating to a “buy” rating in a report on Sunday, November 3rd.

Avanos Medical Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.